We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Are you still an "Indian"? Affordable Care Act may tax those who are not

  • Foster Pepper & Shefelman PLLC
  • -
  • India, USA
  • -
  • May 20 2013

The Affordable Care Act requires all Americans to participate in some form of health care insurance, or else pay an annual tax penalty. People who

Indian biotech association signs MOU with U.S.-based association

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • October 18 2012

The Association of Biotechnology Led Enterprises (ABLE), representing biotechnology interests in India, has reportedly signed a memorandum of understanding (MOU) with the Washington Biotechnology and Biomedical Association (WBBA), Washington state’s life-sciences trade association

FCPA anti-corruption developments: 2012 end of summer round-up

  • Morrison & Foerster LLP
  • -
  • China, France, Global, Haiti, India, Mexico, United Kingdom, USA
  • -
  • October 10 2012

While the temperatures rose this summer, the number of Foreign Corrupt Practices Act enforcement actions seems to have cooled off for the first time in the last five years

Drug companies in India

  • Dorsey & Whitney LLP
  • -
  • India, USA
  • -
  • June 22 2012

US pharmaceutical companies with operations in India may face investigation by the US government

Changes to EAR will ease dual use, space, and medical exports to India

  • Steptoe & Johnson LLP
  • -
  • India, USA
  • -
  • February 1 2011

On January 25, 2011, the Bureau of Industry and Security, Department of Commerce (BIS), eliminated major restrictions contained in the Export Administration Regulations on high-technology trade with India

Large pharmaceutical companies look to buy niche Indian biotech firms

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • January 13 2011

Major pharmaceutical companies are reportedly buying niche biotech firms in India to take advantage of emerging opportunities involving biosimilar drugs, which are expected to have a market share of approximately $78 billion by 2013